Get 20% lifetime commission for referring investors to digrin.com
here.
iTeos Therapeutics, Inc. (ITOS) Financials
Stock symbol ITOS is outdated, potentially delisted? Maybe it is available on other exchange?
ITOS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2025 | 658.9 million | 95.4 million |
| Dec. 31, 2024 | 687.0 million | 96.7 million |
| Sept. 30, 2024 | 723.1 million | 91.4 million |
| June 30, 2024 | 751.8 million | 88.0 million |
ITOS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2025 | -33.9 million | 6.6 million |
| Dec. 31, 2024 | 5.3 million | 7.1 million |
| Sept. 30, 2024 | -37.4 million | 7.5 million |
| June 30, 2024 | -34.4 million | 8.1 million |
ITOS Net Income
No data available :(
ITOS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2025 | 520.4 million | - | 5.1 million |
| Dec. 31, 2024 | 494.6 million | 3.8 million | 5.1 million |
| Sept. 30, 2024 | 488.7 million | 4.2 million | 5.5 million |
| June 30, 2024 | 571.3 million | 4.2 million | 5.5 million |
ITOS Shares Outstanding
ITOS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2025 | 101000 | 29.0 million | 11.0 million | - |
| Dec. 31, 2024 | 152000 | 37.5 million | 11.8 million | - |
| Sept. 30, 2024 | 94000 | 36.7 million | 12.1 million | - |
| June 30, 2024 | 442000 | 36.4 million | 12.5 million | - |
ITOS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2025 | - | - |
| Dec. 31, 2024 | - | - |
| Sept. 30, 2024 | - | - |
| June 30, 2024 | 35.0 million | 309000 |
ITOS Revenue by Segment
Graph available only for paid members. Upgrade to see it.
ITOS
Price: $10.15
52 week price:
Earnings Per Share: -4.73 USD
P/E Ratio: -2.15
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 231111
Market Capitalization: 448.7 million